| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXHL2101458 | PB-201片 | PB-201 | Tablet | Chemical Drugs(1) | New Drug Application | 2021-09-08 | Peg BIO Co Ltd | view | |||
| CXHL2101459 | PB-201片 | PB-201 | Tablet | Chemical Drugs(1) | New Drug Application | 2021-09-08 | Peg BIO Co Ltd | view | |||
| CXHB2101090 | PB-201片 | PB-201 | Tablet | Chemical Drugs(1) | Supplementary Application | 2021-08-23 | Peg BIO Co Ltd | view | |||
| CXHB2101089 | PB-201片 | PB-201 | Tablet | Chemical Drugs(1) | Supplementary Application | 2021-08-23 | Peg BIO Co Ltd | view | |||
| CXHL2101332 | PB-201片 | PB-201 | Tablet | Chemical Drugs(1) | New Drug Application | 2021-07-29 | Peg BIO Co Ltd | view | |||
| CXHL2101333 | PB-201片 | PB-201 | Tablet | Chemical Drugs(1) | New Drug Application | 2021-07-29 | Peg BIO Co Ltd | view | |||
| CXHL1900018 | PB-201片 | PB-201 | Tablet | Chemical Drugs(1) | New Drug Application | 2019-01-14 | 派格生物医药（苏州）有限公司 | Peg BIO Co Ltd | In Review | 2019-01-11 | view |
| CXHL1900019 | PB-201片 | PB-201 | Tablet | Chemical Drugs(1) | New Drug Application | 2019-01-14 | 派格生物医药（苏州）有限公司 | Peg BIO Co Ltd | In Review | 2019-01-11 | view |